Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026
Same author

Discovery of a mutation-containing circRNA in polyglutamine disease through systematic analysis of RNAs with CAG repeats.

RNA biology·2026
Same author

Deep brain stimulation and sleep in Parkinson's disease: unresolved questions and a decade of missing research.

Parkinsonism & related disorders·2026
Same author

Dopamine agonist withdrawal syndrome - what do we really know?

Neurologia i neurochirurgia polska·2026
Same author

Professor Zbigniew K. Wszolek, Co-Editor-in-Chief of Polish Journal of Neurology and Neurosurgery 2017-2025.

Neurologia i neurochirurgia polska·2026
Same author

The underrated value of non-motor symptoms of Parkinson's disease in making diagnostic and treatment decisions.

Neurologia i neurochirurgia polska·2026

Related Experiment Video

Updated: Jun 9, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

[Continuous dopaminergic stimulation - clinical experience].

Andrzej Bogucki1, Jarosław Sławek

  • 1Klinika Chorób Układu Pozapiramidowego, Wydział Fizjoterapii, Uniwersytet Medyczny w Łódzi. andrzej.bogucki@umed.lodz.pl

Neurologia I Neurochirurgia Polska
|September 10, 2010
PubMed
Summary

Continuous dopaminergic stimulation (CDS) helps prevent motor complications like fluctuations and dyskinesia in Parkinson disease (PD) patients on levodopa therapy. Various methods, including dopamine agonists and continuous infusion, can achieve CDS.

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
06:40

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Published on: April 23, 2020

Related Experiment Videos

Last Updated: Jun 9, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine
06:40

Combined Infusion and Stimulation with Fast-Scan Cyclic Voltammetry (CIS-FSCV) to Assess Ventral Tegmental Area Receptor Regulation of Phasic Dopamine

Published on: April 23, 2020

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Parkinson disease (PD) patients on levodopa therapy often develop motor complications, including fluctuations and dyskinesia, within 4-6 years.
  • These complications are linked to disease progression and pulsatile stimulation of dopaminergic receptors.

Purpose of the Study:

  • To explore the concept and methods of achieving continuous dopaminergic stimulation (CDS) to prevent motor complications in Parkinson disease.
  • To review treatment options that provide CDS for managing Parkinson disease.

Main Methods:

  • Review of experimental and clinical studies supporting the concept of CDS.
  • Analysis of treatment strategies including dopamine agonists (oral, transdermal, subcutaneous infusion) and continuous levodopa enteral infusion.

Main Results:

  • Dopamine agonists, when used as monotherapy in early PD, can delay dyskinesia due to their longer half-life.
  • Continuous delivery systems for dopamine agonists (prolonged-release oral, transdermal, subcutaneous infusion) enhance CDS.
  • Continuous enteral levodopa infusion is highly effective in reducing motor complications in advanced PD.

Conclusions:

  • Achieving continuous dopaminergic stimulation (CDS) is crucial for preventing motor complications in Parkinson disease.
  • Various therapeutic strategies, including advanced delivery systems for dopamine agonists and continuous levodopa infusion, can provide CDS.
  • Continuous enteral levodopa infusion offers significant benefits for advanced Parkinson disease patients experiencing motor complications.